Deborah H. Telman - 10 Mar 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
EVP, Corporate Affairs & GC
Signature
/s/ Amy Kim by Power of Attorney for Deborah H. Telman
Issuer symbol
GILD
Transactions as of
10 Mar 2023
Net transactions value
$0
Form type
4
Filing time
13 Mar 2023, 20:50:23 UTC
Previous filing
23 Feb 2023
Next filing
26 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Award +10,220 +31% 43,140 10 Mar 2023 Common Stock 10,220 Direct F1, F2
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +46,605 $0.000000 46,605 10 Mar 2023 Common Stock 46,605 $79.50 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F3 The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.